SCHEMBL16776738

SCHEMBL16776738

COc1ccc(N2CCOCC2)cc1N(C(=O)O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.47
▸ MEN1 O00255 6/20 0.47
▸ HCRTR1 O43613 1/20 0.47
▸ MAPT P10636 8/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ PIK3CD O00329 1/20 0.44
▸ PIK3CA P42336 1/20 0.44
▸ PIK3CB P42338 1/20 0.44
▸ PIK3CG P48736 1/20 0.44
▸ PRKDC P78527 1/20 0.44
▸ PTK2 Q05397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3042604 0.76 MAPT (0.52) KMT2AMEN1HCRTR1MAPTALDH1A1
SCHEMBL1644942 0.75 HIF1A (0.57) KMT2AMEN1HCRTR1MAPTALDH1A1
SCHEMBL4839678 0.72 HIF1A (0.63) KMT2AMEN1HCRTR1MAPTALDH1A1
SCHEMBL10630540 0.72 KMT2A (0.56) KMT2AMEN1MAPTALDH1A1PKM
SCHEMBL19500869 0.72 HIF1A (0.62) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL713040 0.72 PTGIR (0.51) KMT2AMEN1MAPTALDH1A1HTT
SCHEMBL16106421 0.72 MAPT (0.58) KMT2AMEN1HCRTR1MAPTALDH1A1
SCHEMBL1599724 0.71 PRKDC (0.57) KMT2AMEN1MAPTALDH1A1PKM
SCHEMBL16776764 0.71 MAPK14 (0.43) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL4766240 0.71 HIF1A (0.59) KMT2AMEN1HCRTR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166483-A1 KINASE INHIBITORS RESPIVERT LTD (GB) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166483-A1 KINASE INHIBITORS LCK, SYK, FYN KMT2A 3511/4885MEN1 4840/4885HCRTR1 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback